Cargando…
Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
OBJECTIVE: Scheduled endoscopic dilatation of dominant strictures (DS) in primary sclerosing cholangitis (PSC) might improve outcome relative to endoscopic treatment on demand, but evidence is limited. Since randomisation is difficult in clinical practice, we present a large retrospective study comp...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872453/ https://www.ncbi.nlm.nih.gov/pubmed/30910856 http://dx.doi.org/10.1136/gutjnl-2018-316801 |
_version_ | 1783472492080267264 |
---|---|
author | Rupp, Christian Hippchen, Theresa Bruckner, Thomas Klöters-Plachky, Petra Schaible, Anja Koschny, Ronald Stiehl, Adolf Gotthardt, Daniel Nils Sauer, Peter |
author_facet | Rupp, Christian Hippchen, Theresa Bruckner, Thomas Klöters-Plachky, Petra Schaible, Anja Koschny, Ronald Stiehl, Adolf Gotthardt, Daniel Nils Sauer, Peter |
author_sort | Rupp, Christian |
collection | PubMed |
description | OBJECTIVE: Scheduled endoscopic dilatation of dominant strictures (DS) in primary sclerosing cholangitis (PSC) might improve outcome relative to endoscopic treatment on demand, but evidence is limited. Since randomisation is difficult in clinical practice, we present a large retrospective study comparing scheduled versus on-demand endoscopic retrograde cholangiopancreatography (ERCP) based on patient preferences. DESIGN: Between 1987 and 2017, all new patients with PSC had been offered scheduled ERCP with dilatation of a DS if diagnosed; the latter was repeated at defined intervals until morphological resolution, independent of clinical symptoms (treatment group). Patients who refused participation were clinically evaluated annually and received endoscopic treatment only on demand (control group). The primary clinical endpoint was transplantation-free survival. Secondary outcomes were overall survival, bacterial cholangitis episodes, hepatic decompensation of liver cirrhosis and endoscopy-related adverse events. RESULTS: The final study included 286 patients, 133 (46.5%) receiving scheduled ERCP and 153 (53.5%) receiving on-demand ERCP. After a mean follow-up of 9.9 years, the rate of transplantation-free survival was higher in patients receiving scheduled ERCP (51% vs 29.3%; p<0.001), as was transplantation-free survival time (median: 17.9 vs 15.2 years; log-rank: p=0.008). However, the benefit of scheduled ERCP was significant only in patients with the initial (17.1%) or later (45.5%) diagnosis of a DS (17.8 vs 11.1 years; log-rank: p<0.001). IBD (p=0.03), DS (p=0.006), higher Mayo Risk Score (p=0.02) and non-adherence to scheduled endoscopy (p=0.005) were independently associated with transplantation-free survival. CONCLUSION: In our large retrospective study, regular ERCP with endoscopic balloon dilatation significantly benefits patients with PSC with DS, diagnosed both at initial presentation and during surveillance, even if asymptomatic. Further studies have to find out how to best identify stricture patients non-invasively. |
format | Online Article Text |
id | pubmed-6872453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-68724532019-12-04 Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis Rupp, Christian Hippchen, Theresa Bruckner, Thomas Klöters-Plachky, Petra Schaible, Anja Koschny, Ronald Stiehl, Adolf Gotthardt, Daniel Nils Sauer, Peter Gut Endoscopy OBJECTIVE: Scheduled endoscopic dilatation of dominant strictures (DS) in primary sclerosing cholangitis (PSC) might improve outcome relative to endoscopic treatment on demand, but evidence is limited. Since randomisation is difficult in clinical practice, we present a large retrospective study comparing scheduled versus on-demand endoscopic retrograde cholangiopancreatography (ERCP) based on patient preferences. DESIGN: Between 1987 and 2017, all new patients with PSC had been offered scheduled ERCP with dilatation of a DS if diagnosed; the latter was repeated at defined intervals until morphological resolution, independent of clinical symptoms (treatment group). Patients who refused participation were clinically evaluated annually and received endoscopic treatment only on demand (control group). The primary clinical endpoint was transplantation-free survival. Secondary outcomes were overall survival, bacterial cholangitis episodes, hepatic decompensation of liver cirrhosis and endoscopy-related adverse events. RESULTS: The final study included 286 patients, 133 (46.5%) receiving scheduled ERCP and 153 (53.5%) receiving on-demand ERCP. After a mean follow-up of 9.9 years, the rate of transplantation-free survival was higher in patients receiving scheduled ERCP (51% vs 29.3%; p<0.001), as was transplantation-free survival time (median: 17.9 vs 15.2 years; log-rank: p=0.008). However, the benefit of scheduled ERCP was significant only in patients with the initial (17.1%) or later (45.5%) diagnosis of a DS (17.8 vs 11.1 years; log-rank: p<0.001). IBD (p=0.03), DS (p=0.006), higher Mayo Risk Score (p=0.02) and non-adherence to scheduled endoscopy (p=0.005) were independently associated with transplantation-free survival. CONCLUSION: In our large retrospective study, regular ERCP with endoscopic balloon dilatation significantly benefits patients with PSC with DS, diagnosed both at initial presentation and during surveillance, even if asymptomatic. Further studies have to find out how to best identify stricture patients non-invasively. BMJ Publishing Group 2019-12 2019-03-25 /pmc/articles/PMC6872453/ /pubmed/30910856 http://dx.doi.org/10.1136/gutjnl-2018-316801 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Endoscopy Rupp, Christian Hippchen, Theresa Bruckner, Thomas Klöters-Plachky, Petra Schaible, Anja Koschny, Ronald Stiehl, Adolf Gotthardt, Daniel Nils Sauer, Peter Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis |
title | Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis |
title_full | Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis |
title_fullStr | Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis |
title_full_unstemmed | Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis |
title_short | Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis |
title_sort | effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis |
topic | Endoscopy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872453/ https://www.ncbi.nlm.nih.gov/pubmed/30910856 http://dx.doi.org/10.1136/gutjnl-2018-316801 |
work_keys_str_mv | AT ruppchristian effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis AT hippchentheresa effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis AT brucknerthomas effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis AT klotersplachkypetra effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis AT schaibleanja effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis AT koschnyronald effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis AT stiehladolf effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis AT gotthardtdanielnils effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis AT sauerpeter effectofscheduledendoscopicdilatationofdominantstricturesonoutcomeinpatientswithprimarysclerosingcholangitis |